GoodRx Holdings, Inc. Class A (GDRX)

30.57
0.89 2.81
NASDAQ
Prev Close 31.45
Open 29.80
Day Low/High 29.40 / 30.88
52 Wk Low/High 33.51 / 64.22
Volume 1.40M
Exchange NASDAQ
Shares Outstanding 397.86B
Market Cap 13.82B
Div & Yield N.A. (N.A)

Have the charts improved over the last few months?

We can still look forward to that always elusive 'follow through' day for the Nasdaq.

IPOs in recent months have done extremely well -- not so GDRX.

Traders have to take the extra step to understand the underlying company and sector before jumping into a position.

The good news is that my trade offered an opportunity for a quick profit. The bad news is it didn't last very long.

Trading volume was low enough Wednesday to indicate a lack of conviction, or conviction that did not spread across enough managers to truly change the narrative.

Definitely put this one on the highly speculative side.

GDRX will not stay in a tight range for long.

Let's Checkup on GoodRx

Let's Checkup on GoodRx

Have the charts improved over the last few months?

Doors and Catalysts, Nasdaq Resistance, China Trouble? Trading Defense Stocks

Doors and Catalysts, Nasdaq Resistance, China Trouble? Trading Defense Stocks

We can still look forward to that always elusive 'follow through' day for the Nasdaq.

GoodRx Needs a Shot in the Arm to Improve Its Outlook

GoodRx Needs a Shot in the Arm to Improve Its Outlook

IPOs in recent months have done extremely well -- not so GDRX.

Out for a Scalp? Not So Fast

Out for a Scalp? Not So Fast

Traders have to take the extra step to understand the underlying company and sector before jumping into a position.

I'll Take My Medicine on GoodRx

I'll Take My Medicine on GoodRx

The good news is that my trade offered an opportunity for a quick profit. The bad news is it didn't last very long.

Indecisive Markets, RealClearPolitics, Infection Surge, Moderna, Disney Earnings

Indecisive Markets, RealClearPolitics, Infection Surge, Moderna, Disney Earnings

Trading volume was low enough Wednesday to indicate a lack of conviction, or conviction that did not spread across enough managers to truly change the narrative.

GoodRX Has Struggled to Gain Momentum but That May Be Changing

GoodRX Has Struggled to Gain Momentum but That May Be Changing

Definitely put this one on the highly speculative side.

GoodRx Hasn't Been Public Long But Here's What We Know

GoodRx Hasn't Been Public Long But Here's What We Know

GDRX will not stay in a tight range for long.